Related Experiment Video
Updated: Jun 20, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Thyroid receptor: roles in cancer
Ana Aranda1, Olaia Martínez-Iglesias, Lidia Ruiz-Llorente
1Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid, Arturo Duperier 4, 28029 Madrid, Spain. aaranda@iib.uam.es
Abstract:
The thyroid hormone receptors, encoded by the TRalpha and TRbeta genes, are ligand-dependent transcription factors that belong to the nuclear receptor superfamily. In addition to the role of these receptors in growth, development and metabolism, there is increasing evidence that they also inhibit transformation and act as tumor suppressors. Aberrant TR action, as well as receptor silencing, are common events in human cancer, and TRs also have an important role in tumor progression in experimental animal models, suggesting that these receptors constitute a novel therapeutic target in cancer. This review highlights recent studies on mechanisms by which loss of expression and/or function of these receptors results in a selective advantage for cellular transformation, tumor development and metastatic growth.
Insights
Thyroid hormone receptors (TRs) are crucial for development and metabolism. Recent findings reveal TRs act as tumor suppressors, and their loss promotes cancer growth and metastasis, indicating TRs as a novel cancer therapeutic target.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Thyroid hormone receptors (TRs), members of the nuclear receptor superfamily, regulate critical physiological processes.
- TRs are increasingly recognized for their role in inhibiting cellular transformation and acting as tumor suppressors.
- Dysregulation and silencing of TRs are frequently observed in human cancers.
Purpose of the Study:
- To review recent studies on the mechanisms underlying TR loss of function in cancer.
- To highlight the role of TRs in tumor development and metastatic growth.
- To underscore the potential of TRs as a novel therapeutic target in oncology.
Main Methods:
- Literature review of recent studies on thyroid hormone receptors and cancer.
- Analysis of mechanisms involving TR expression and function in cellular transformation.
- Examination of TRs' role in tumor progression in experimental models.
Main Results:
- Loss of TR expression or function provides a selective advantage for cellular transformation.
- TRs play a significant role in tumor development and metastatic spread.
- Aberrant TR action is a common event in human cancer.
Conclusions:
- Thyroid hormone receptors are critical tumor suppressors.
- Mechanisms of TR loss contribute to cancer progression.
- TRs represent a promising therapeutic target for cancer treatment.
Related Concept Videos
Mitogens and the Cell Cycle
Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
